Skip to main content

Sally Howard

Human Longevity has appointed Sally Howard as head of regulatory affairs and policy. She will lead all efforts related to federal and state regulatory oversight for the company. Howard comes to Human Longevity from the US Food and Drug Administration, where she most recently served as senior advisor and acting chief of staff to the FDA commissioner. Before that she spent two years as FDA deputy commissioner for policy, planning, and legislation. Prior to her positions at the FDA, Howard spent two years as chief of staff at the US Department of Health and Human Services.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.